Regenxbio Inc President and CEO Kenneth Mills Sells 45,000 Shares

Kenneth Mills, President and CEO of Regenxbio Inc (NASDAQ:RGNX), executed a sale of 45,000 shares in the company on December 19, 2023, according to a recent SEC Filing.

Related Keywords

,Regenxbio Inc ,Gurufocus Value ,Fairly Valued ,Kenneth Mills ,Biotechnology Company ,